Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.51 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.51 |
| ▸ | HTR3B | O95264 | 1/20 | 0.51 |
| ▸ | HTR3A | P46098 | 1/20 | 0.51 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.51 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.51 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.50 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | SCN1A | P35498 | 1/20 | 0.46 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.46 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.46 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.45 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.45 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL469812 | 1.00 | MEN1 (0.52) | MEN1KMT2ACHRNA7HTR3EHTR3B | |
| SCHEMBL31113478 | 0.85 | PTPN2 (0.57) | MEN1KMT2ASCN1ASCN2ASCN3A | |
| SCHEMBL32678657 | 0.84 | BCHE (0.46) | BCHE | |
| SCHEMBL32678656 | 0.84 | BCHE (0.46) | BCHE | |
| SCHEMBL31113601 | 0.84 | ALDH1A1 (0.49) | KMT2AGAABCHELMNATDP1 | |
| SCHEMBL11636361 | 0.83 | MEN1 (0.53) | MEN1KMT2ACHRNA7HTR3EHTR3B | |
| SCHEMBL4453290 | 0.80 | MEN1 (0.69) | MEN1KMT2ACHRNA7HTR3EHTR3B | |
| SCHEMBL1786140 | 0.80 | MEN1 (0.69) | MEN1KMT2ACHRNA7HTR3EHTR3B | |
| SCHEMBL1564914 | 0.79 | CHRNA7 (0.48) | MEN1KMT2ACHRNA7HTR3EHTR3B | |
| SCHEMBL29949611 | 0.79 | CHRNA7 (0.48) | MEN1KMT2ACHRNA7HTR3EHTR3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683641-A1 | AZITHROMYCIN DERIVATIVES FOR USE IN THE TREATMENT OF EOSINOPHIL-RELATED DISEASES | EpiEndo Pharmaceuticals ehf. (IS) | 2026-01-28 | — | — | EP | claimed |
| WO-2024194494-A1 | AZITHROMYCIN DERIVATIVES FOR USE IN THE TREATMENT OF EOSINOPHIL-RELATED DISEASES | EPIENDO PHARMACEUTICALS EHF (IS) | 2024-09-26 | — | — | WO | claimed |
| WO-2026041802-A1 | AZITHROMYCIN DERIVATIVES FOR USE IN THE TREATMENT OF INFECTIONS | EPIENDO PHARMACEUTICALS EHF (IS) | 2026-02-26 | — | — | WO | disclosed |
| EP-4683641-A1 | AZITHROMYCIN DERIVATIVES FOR USE IN THE TREATMENT OF EOSINOPHIL-RELATED DISEASES | EpiEndo Pharmaceuticals ehf. (IS) | 2026-01-28 | — | — | EP | disclosed |
| CN-120152721-A | Treatment of familial adenomatous polyposis with 13-membered macrolides | 齐卡尼治疗股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119731188-A | Synthetic methods and intermediates for preparing therapeutic azaketolides | 齐卡尼治疗股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2024194494-A1 | AZITHROMYCIN DERIVATIVES FOR USE IN THE TREATMENT OF EOSINOPHIL-RELATED DISEASES | EPIENDO PHARMACEUTICALS EHF (IS) | 2024-09-26 | — | — | WO | disclosed |
| EP-4358970-A1 | COMPOUNDS FOR TREATING GENETIC DISEASES | Zikani Therapeutics, Inc. (US) | 2024-05-01 | — | — | EP | disclosed |
| WO-2023250513-A1 | 13-MEMBERED MACROLIDE COMPOUNDS FOR TREATING DISEASES MEDIATED BY ABNORMAL PROTEIN TRANSLATION | ZIKANI THERAPEUTICS, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023235380-A1 | MACROLIDES FOR TREATING GENETIC DISEASES | ZIKANI THERAPEUTICS, INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| WO-2022251730-A1 | COMPOUNDS FOR TREATING GENETIC DISEASES | ZIKANI THERAPEUTICS, INC. (US) | 2022-12-01 | — | — | WO | disclosed |